Seegene Inc (096530) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.037x

Based on the latest financial reports, Seegene Inc (096530) has a cash flow conversion efficiency ratio of 0.037x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩37.18 Billion ≈ $25.20 Million USD) by net assets (₩1.00 Trillion ≈ $679.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Seegene Inc balance sheet independence to measure how much of total assets are equity-financed.

Seegene Inc - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Seegene Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 096530 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Seegene Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Seegene Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
HMC Capital Ltd AU:HMC	0.015x
PT Arkora Hydro Tbk JK:ARKO	-0.153x
Guangzhou Automobile Group Co. Ltd F:02G	0.001x
ENEFIT GREEN AS F:I6B	0.056x
Kodiak AI, Inc. Common Stock NASDAQ:KDK	1.297x
Cansino Biologics Inc SHG:688185	0.003x
PMB Technology Bhd KLSE:7172	-0.025x
Multi Bintang Indonesia Tbk JK:MLBI	0.329x

Annual Cash Flow Conversion Efficiency for Seegene Inc (2012–2024)

The table below shows the annual cash flow conversion efficiency of Seegene Inc from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see Seegene Inc (096530) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩981.48 Billion ≈ $665.13 Million	₩85.39 Billion ≈ $57.87 Million	0.087x	-5.57%
2023-12-31	₩1.03 Trillion ≈ $698.29 Million	₩94.93 Billion ≈ $64.33 Million	0.092x	-66.85%
2022-12-31	₩1.15 Trillion ≈ $777.83 Million	₩319.01 Billion ≈ $216.19 Million	0.278x	-10.02%
2021-12-31	₩1.08 Trillion ≈ $732.85 Million	₩334.02 Billion ≈ $226.36 Million	0.309x	-47.98%
2020-12-31	₩645.32 Billion ≈ $437.32 Million	₩383.16 Billion ≈ $259.66 Million	0.594x	+233.73%
2019-12-31	₩152.55 Billion ≈ $103.38 Million	₩27.14 Billion ≈ $18.39 Million	0.178x	+62.59%
2018-12-31	₩128.03 Billion ≈ $86.76 Million	₩14.01 Billion ≈ $9.49 Million	0.109x	+35.27%
2017-12-31	₩125.04 Billion ≈ $84.74 Million	₩10.12 Billion ≈ $6.86 Million	0.081x	-30.63%
2016-12-31	₩141.97 Billion ≈ $96.21 Million	₩16.56 Billion ≈ $11.22 Million	0.117x	+612.54%
2015-12-31	₩135.09 Billion ≈ $91.55 Million	₩-3.07 Billion ≈ $-2.08 Million	-0.023x	-131.84%
2014-12-31	₩94.83 Billion ≈ $64.27 Million	₩6.78 Billion ≈ $4.59 Million	0.071x	+308.60%
2013-12-31	₩84.44 Billion ≈ $57.23 Million	₩-2.89 Billion ≈ $-1.96 Million	-0.034x	-139.12%
2012-12-31	₩41.94 Billion ≈ $28.42 Million	₩3.67 Billion ≈ $2.49 Million	0.088x	--

About Seegene Inc

KQ:096530 Korea Biotechnology

Market Cap

$840.63 Million

₩1.24 Trillion KRW

Market Cap Rank

#9507 Global

#238 in Korea

Share Price

₩26900.00

Change (1 day)

+6.96%

52-Week Range

₩21850.00 - ₩32000.00

All Time High

₩140042.88